Daniel Prieto Romero
Gerontology · Orlando, FLNPI 1598207300
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,635 of the $9,133 with a category attached, or 61.7%. 26 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 31.9% of the total. Reporting peaked in 2021 at $3,856 and has fallen 66.1% since, to $1,308 in 2025. Among gerontology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 324 payments — averaging $28.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$3K
- Collegium Pharmaceutical, Inc.$2K
- Boston Scientific$1K
- AbbVie$950
- Biohaven Pharmaceuticals, Inc.$817
- Amgen$279
- plus $1K from 20 others
What the payments were for
- Consulting fees$8009%
- Speaking & faculty fees$1,84020%
- Travel & lodging$8379%
- Food & beverage$5,63562%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 81 | $2,915 |
| Collegium Pharmaceutical, Inc. | 106 | $1,591 |
| Boston Scientific | 11 | $1,116 |
| AbbVie(2 entities) | 48 | $950 |
| Biohaven Pharmaceuticals, Inc. | 2 | $817 |
| Amgen | 6 | $279 |
| Pfizer | 16 | $235 |
| Protega Pharmaceutials Inc | 7 | $205 |
| Nevro Corp. | 5 | $160 |
| Teva Pharmaceuticals USA, Inc. | 4 | $148 |
| Abbott | 6 | $119 |
| Agios Pharmaceuticals, Inc. | 6 | $114 |
| Scilex Pharmaceuticals Inc. | 6 | $89 |
| Saluda Medical Americas, Inc. | 2 | $69 |
| Biodelivery Sciences International, Inc. | 3 | $51 |
| Azurity Pharmaceuticals, Inc. | 2 | $37 |
| Atland Pharmaceuticals, LLC | 1 | $33 |
| Lilly USA, LLC | 2 | $33 |
| Valinor Pharma, LLC | 2 | $32 |
| Globus Medical | 1 | $28 |
| Medtronic | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Stimwave Technologies Incorporated | 2 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Nalu Medical, Inc. | 1 | $18 |
| Painteq LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RELISTOR$1,948
- Intracept$817
- NURTEC ODT$800
- AIMOVIG$228
- AJOVY$106
How this compares
$9,133 in reported general payments places this provider in the 95th percentile of 714 gerontology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 30 | $85,048 |
| UbrelvyUbrogepant | 25 | $72,850 |
| ZtlidoLidocaine | 40 | $42,940 |
| Nurtec OdtRimegepant Sulfate | 17 | $32,389 |
| BotoxOnabotulinumtoxina | 19 | $24,442 |
| Methocarbamol | 412 | $21,562 |
| BelbucaBuprenorphine Hcl | 20 | $14,661 |
| Gabapentin | 855 | $12,936 |
| MovantikNaloxegol Oxalate | 20 | $12,675 |
| Pregabalin | 428 | $12,215 |
| Chlorzoxazone | 32 | $9,953 |
| LyricaPregabalin | 11 | $9,810 |
| Duloxetine Hcl | 414 | $9,049 |
| Emgality SyringeGalcanezumab-Gnlm | 12 | $8,136 |
| Lidocaine | 54 | $6,129 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Botox | $950 | $97,29244 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $2,915 | $85,04830 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $89 | $42,94040 claims |
| PfizerNurtec Odt, Lyrica | $235 | $42,19928 claims |
| Collegium Pharmaceutical, Inc.Belbuca | $1,591 | $14,66120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 714 gerontology providers in Florida.
Other gerontology in Orlando
- Boni MayOrlando$22K
- Michelle ChanceOrlando$7K
- Jing LiuOrlando$6K
- Flavius NascimentoCoral Springs$226K
- Michelle HartogWinter Park$90K
- Alejandra Rosales-CohenOrange City$88K
- Jennifer PacilettiAtlantis$66K
- Tatiana ClarkBradenton$34K
- Brandi LigonWinter Park$27K
- Dennis VerducciMiami$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.